Health

HPV vaccine approved for people through age 45

(HealthDay)—U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release.

Oncology & Cancer

New HPV vaccine strengthens cancer protection

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.

Diseases, Conditions, Syndromes

Colombian president: No link of vaccine to illness

Colombia's president is dismissing suggestions that a vaccine against cervical cancer is causing a mystery illness that has affected scores of teenage girls in a northern city.

Diseases, Conditions, Syndromes

Three doses of HPV vaccine recommended against genital warts

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

page 1 from 2